* Aethlon Medical Inc reported a quarterly adjusted loss of 20 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-1.22. The mean expectation of two analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -20 cents to -19 cents per share.

* Reported revenue was zero​; analysts expected zero.

* Aethlon Medical Inc's reported EPS for the quarter was a loss of 20 cents​.

* The company reported a quarterly loss of $2.81 million.

* Aethlon Medical Inc shares had fallen by 15.6% this quarter and lost 82.0% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts was unchanged in the last three months.​

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."

Wall Street's median 12-month price target for Aethlon Medical Inc is $3.86 This summary was machine generated from LSEG data November 14 at 03:53 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.19 -0.20 Missed

Jun. 30 2024 -0.31 -0.34 Missed

Mar. 31 2024 -1.23 -0.91 Beat

Dec. 31 2023 -1.23 -1.37 Missed